Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Velocity vector imaging echocardiography and NT-proBNP study of fetal cardiac function in pregnancy-induced maternal hypertension.

Yu L, Zhou Q, Peng Q, Zeng S, Yang Z.

J Clin Ultrasound. 2019 Mar 18. doi: 10.1002/jcu.22720. [Epub ahead of print]

PMID:
30883813
2.
3.

Left ventricular function of patients with pregnancy-induced hypertension evaluated using velocity vector imaging echocardiography and N-terminal pro-brain natriuretic peptide.

Yu L, Zhou Q, Peng Q, Yang Z.

Echocardiography. 2018 Apr;35(4):459-466. doi: 10.1111/echo.13817. Epub 2018 Feb 11.

PMID:
29430691
4.

Impaired fetal myocardial deformation in intrahepatic cholestasis of pregnancy.

Fan X, Zhou Q, Zeng S, Zhou J, Peng Q, Zhang M, Ding Y.

J Ultrasound Med. 2014 Jul;33(7):1171-7. doi: 10.7863/ultra.33.7.1171.

PMID:
24958403
5.

Comparison of the right and left ventricular performance during the fetal development using velocity vector imaging.

Kim SH, Miyakoshi K, Kadohira I, Tanaka M, Minegishi K, Matsumoto T, Yoshimura Y.

Early Hum Dev. 2013 Sep;89(9):675-81. doi: 10.1016/j.earlhumdev.2013.04.015. Epub 2013 May 23.

PMID:
23707047
6.

N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.

Dong SJ, de las Fuentes L, Brown AL, Waggoner AD, Ewald GA, Dávila-Román VG.

J Am Soc Echocardiogr. 2006 Aug;19(8):1017-25.

PMID:
16880097
7.
8.

Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants.

Mert MK, Satar M, Özbarlas N, Yaman A, Özgünen FT, Asker HS, Çekinmez EK, Tetiker T.

Pediatr Cardiol. 2016 Jan;37(1):76-83. doi: 10.1007/s00246-015-1242-1. Epub 2015 Aug 13.

PMID:
26266327
9.

Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.

Ciurzyński M, Bienias P, Lichodziejewska B, Kurnicka K, Szewczyk A, Glińska-Wielochowska M, Kurzyna M, Błaszczyk M, Liszewska-Pfejfer D, Pruszczyk P.

Clin Rheumatol. 2008 Aug;27(8):991-7. doi: 10.1007/s10067-008-0837-9. Epub 2008 Feb 7.

PMID:
18256871
10.

Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.

Weiner RB, Baggish AL, Chen-Tournoux A, Marshall JE, Gaggin HK, Bhardwaj A, Mohammed AA, Rehman SU, Barajas L, Barajas J, Gregory SA, Moore SA, Semigran MJ, Januzzi JL Jr.

Eur J Heart Fail. 2013 Mar;15(3):342-51. doi: 10.1093/eurjhf/hfs180. Epub 2012 Nov 6.

11.

NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function.

Pasha SM, Klok FA, van der Bijl N, de Roos A, Kroft LJ, Huisman MV.

Thromb Haemost. 2012 Aug;108(2):367-72. doi: 10.1160/TH11-12-0901. Epub 2012 Jun 28.

PMID:
22740123
12.

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus.

Sadlecki P, Grabiec M, Walentowicz-Sadlecka M.

PLoS One. 2016 Sep 29;11(9):e0162957. doi: 10.1371/journal.pone.0162957. eCollection 2016.

13.

Tissue doppler imaging and NT-proBNP levels show the early impairment of ventricular function in patients with beta-thalassaemia major.

Akpinar O, Acartürk E, Kanadaşi M, Unsal C, Başlamişli F.

Acta Cardiol. 2007 Jun;62(3):225-31.

PMID:
17608095
14.

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.

Eindhoven JA, van den Bosch AE, Ruys TP, Opić P, Cuypers JA, McGhie JS, Witsenburg M, Boersma E, Roos-Hesselink JW.

J Am Coll Cardiol. 2013 Sep 24;62(13):1203-12. doi: 10.1016/j.jacc.2013.07.019. Epub 2013 Jul 31.

15.

NT-proBNP correlated with strain and strain rate imaging of the right ventricle before and after transcatheter closure of atrial septal defects.

Elsheikh RG, Hegab M, Szatmari A.

J Saudi Heart Assoc. 2013 Jan;25(1):3-8. doi: 10.1016/j.jsha.2012.08.003. Epub 2012 Oct 13.

16.
17.

Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.

Krzesiński P, Uziebło-Życzkowska B, Gielerak G, Stańczyk A, Piotrowicz K, Piechota W, Smurzyński P, Skrobowski A.

Adv Clin Exp Med. 2017 Mar-Apr;26(2):295-301. doi: 10.17219/acem/33554.

18.

N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations.

Merz WM, Kübler K, Albers E, Stoffel-Wagner B, Gembruch U.

Clin Res Cardiol. 2012 Feb;101(2):73-9. doi: 10.1007/s00392-011-0366-4. Epub 2011 Sep 29.

PMID:
21960417
19.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
20.

Study of Regional Left Ventricular Longitudinal Function in Fetuses with Gestational Diabetes Mellitus by Velocity Vector Imaging.

Wang X, Lian Y, Wang X, Tian M.

Echocardiography. 2016 Aug;33(8):1228-33. doi: 10.1111/echo.13238. Epub 2016 Jul 26.

PMID:
27460645

Supplemental Content

Support Center